La. Admin. Code tit. 46 § XLV-7403
A. As used in this Chapter, unless the content clearly states otherwise, the following terms and phrases shall have the meanings specified.
Board- the Louisiana State Board of Medical Examiners, as constituted in the Medical Practice Act.
Collaborative Drug Therapy Advisory Committee or Advisory Committee- the Louisiana State Board of Medical Examiners' Collaborative Drug Therapy Advisory Committee, as constituted under §7417 of this Chapter.
Collaborative Drug Therapy Management or Drug Therapy Management- that practice in which a pharmacist voluntarily agrees with a physician to manage the disease specific drug therapy of one or more patients of such physician, within a predetermined range of medication selected by the physician and set forth in a patient specific written order set . Drug therapy management shall be limited to:
a. monitoring and modifying a disease specific drug therapy;
b. collecting and reviewing patient history;
c. obtaining and reviewing vital signs, including pulse, temperature, blood pressure and respiration;
d. ordering, evaluating, and applying the results of laboratory tests directly related to the disease specific drug therapy being managed under an order set, provided such tests do not require the pharmacist to interpret such testing or formulate a diagnosis; and
e. providing disease or condition specific patient education and counseling.
Controlled Substance- any substance defined, enumerated, or included in federal or state statute or regulations 21 CFR 1308.11 -.15 or R.S. 40:964, or any substance which may hereafter be designated as a controlled substance by amendment or supplementation of such regulations or statute.
Disease Specific Drug Therapy- a specific drug(s) prescribed by a physician for a specific patient of such physician that is generally accepted within the standard of care for the treatment of the disease or condition.
Drug- a legend drug.
Drugs of Concern- a drug that is not a controlled substance but which is nevertheless defined and identified, in accordance with the procedures established by the Louisiana Prescription Monitoring Program Act, R.S. 40:1001-1014, as a drug with the potential for abuse.
Legend Drug- for purposes of this Chapter, any drug bearing on the label of the manufacturer or distributor as required by the Food and Drug Administration, the statement "Caution: Federal law prohibits dispensing without a prescription" or "Rx Only." For purposes of this Chapter, legend drugs do not include controlled substances.
Medical Practice Act or the Act- R.S. 37:1261-92 as may be amended from time to time.
Medication- except in these rules where its use may indicate otherwise, is synonymous with drug, as defined herein.
Order Set- a written set of directives or instructions containing each of the components specified by §7429 of this Chapter for collaborative drug therapy management of disease specific drug therapy for a specific patient. The order set shall be signed by the physician and represents the physician orders for the collaborative drug therapy management to be provided to the patient.
Pharmacist- for purposes of this Chapter an individual who has a current, unrestricted license to practice pharmacy in this state duly issued by the Louisiana Board of Pharmacy, who is approved by the Louisiana Board of Pharmacy to engage in collaborative practice for a specific disease or condition based on the pharmacist's training and experience.
Physician- an individual lawfully entitled to engage in the practice of medicine in this state as evidenced by a current, unrestricted license duly issued by the board.
Prescribe- a request or order transmitted in writing, orally, electronically or by other means of telecommunication for a drug that is issued in good faith, in the usual course of professional practice and for a legitimate medical purpose, by a physician for the purpose of correcting a physical, mental, or bodily ailment of his/her patient.
La. Admin. Code tit. 46, § XLV-7403